Opportunistic bone density assessment using pre-treatment [18F]FDG-PET/CT identifies fracture risk in lymphoma patients undergoing corticosteroid-containing chemotherapy
Genevieve Douglas,
Kane M. Nicholls,
Erin Paul,
Zoe Loh,
Sze-Ting Lee,
Kathryn L Hackman,
Cherie Chiang,
Niamh Waters,
Geoffrey Chong,
Ashvind Prabahran,
Eliza A. Hawkes
Affiliations
Genevieve Douglas
Clinical Haematology, Austin Health, Heidelberg; Lymphoma Clinical Innovations Group, Olivia Newton John Cancer and Research Institute, Austin Hospital
Kane M. Nicholls
Radiology Department, Austin Health Heidelberg; Department of Molecular Imaging and Therapy, Austin Health
Erin Paul
Department of Molecular Imaging and Therapy, Austin Health
Zoe Loh
Clinical Haematology, Austin Health
Sze-Ting Lee
Radiology Department, Austin Health Heidelberg; Department of Molecular Imaging and Therapy, Austin Health, Heidelberg; Department of Medicine, University of Melbourne
Kathryn L Hackman
Department of Endocrinology and Diabetes, Alfred Health, Melbourne; Department of Medicine, Monash University, Melbourne
Cherie Chiang
Department of Medicine, University of Melbourne, Melbourne; Department of Endocrinology, Austin Health
Niamh Waters
Clinical Haematology, Austin Health, Heidelberg; Lymphoma Clinical Innovations Group, Olivia Newton John Cancer and Research Institute, Austin Hospital
Geoffrey Chong
Lymphoma Clinical Innovations Group, Olivia Newton John Cancer and Research Institute, Austin Hospital, Heidelberg; Department of Medicine, University of Melbourne, Melbourne; Department of Medical Oncology, Austin Hospital
Clinical Haematology, Austin Health, Heidelberg; Lymphoma Clinical Innovations Group, Olivia Newton John Cancer and Research Institute, Austin Hospital, Heidelberg; Department of Medicine, University of Melbourne, Melbourne; Department of Medical Oncology, Austin Hospital, Heidelberg; School of Public Health and Preventative Medicine, Monash University